Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion

Y. Zhou, X. Zeng, Y. Wu, D. Xue, X. Tan (Guangzhou, China)

Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Session: Diagnostic aspects in thoracic oncology
Session type: Thematic Poster Session
Number: 2616
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Zhou, X. Zeng, Y. Wu, D. Xue, X. Tan (Guangzhou, China). Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion. Eur Respir J 2008; 32: Suppl. 52, 2616

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer
Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020
Year: 2021



Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Diagnostic significance of ADAM8 and M2-PK in non-small cell lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013



An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Year: 2007


Pleural effusions in lung cancer
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012

Visceral pleural invasion is an invasive and aggressive indicator of nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=264
Year: 2006

Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006

Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006

Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017